Very low acute toxicity of three fractions per day accelerated radiotherapy given after induction chemotherapy and surgery in stage III non-small cell lung cancer

Lung Cancer

Volumn 30, Issue 2, 2000, Pages 149-150

  De Pas, Tommaso ^a   Catalano, Giampiero ^a   Pastorino, Ugo ^a   De Braud, Filippo ^a   Jereczek Fossa, Barbara ^a   Spaggiari, Lorenzo ^a   Orecchia, Roberto ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE TOXICITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; MEDIASTINOSCOPY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; TUMOR LOCALIZATION;

CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; RADIOTHERAPY;

EID: 0033728069     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00143-4     Document Type: Letter

References (7)

1. Continuous hyperfractinated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: A randomised multicentre trial
2. Improved survival in stage Ill non-small cell lung cancer: 7 year follow-up of CALGB 8433 trial
3. Radiation therapy oncology group (RTOG) 88-08 and Eastern co-operative oncology group 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non small cell lung cancer
4. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials
5. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer: A meta-analysis
6. Optimal two stage designs for phase II clinical trials
7. Design for efficient clinical trials